HOME >> BIOLOGY >> NEWS
Sea Grant study finds Chinese mitten crabs appear free of human parasite lung flukes

nvasive nuisance species elsewhere. The crabs were first identified in California in 1992, after a shrimp trawler working the South San Francisco Bay hauled up a strange looking crab with fuzzy claws.

However, the crab most likely was introduced to San Francisco South Bay much earlier, in the late 1980s. A hearty and fecund invader, the crab has multiplied to such numbers that it now overruns parts of the bay. In 1998, state workers hauled away about 50 tons worth of mitten crabs that had clogged fish screens at state water pumps near Tracy. Besides clogging fish salvage tanks, mitten crab burrows undermine banks and levees, accelerating erosion and unwanted slumping.

To date, there are no strategies in place for controlling the crab's numbers. Fishers are suggesting that the crab population be culled by opening the mitten crab to commercial fishing, but this is problematic, too.

Dugan said, "The idea is to figure out a way to get rid of the crabs. If you open a fishery, suddenly, they have a value."

Another concern is that parasites could spread like fire in a hayloft through the bay at some later date, because of the sheer number of crabs. Not just people but also raccoons and other animals that feed on mitten crabs could be infected.

Because crayfish are a potential intermediate host for the flukes, the scientists also dissected more than 400 crayfish from the estuary. Like the crabs, all the crayfish appear free of lung flukes.

Despite their findings, the scientists are cautious about concluding that eating the crabs is safe now or in the future.

"Until we finish our survey of the region's snails," Walter said, "we can't assess the risk of future introductions of lung flukes."

The scientists are in the process of analyzing hundreds of freshwater snails from the area to look for evidence of lung flukes. Even if the snails turn up clean, Culver said, there are other major health concerns - such as b
'"/>

Contact: Carrie Culver
c_culver@lifesci.ucsb.edu
805-893-8093
National Sea Grant College Program
14-Nov-2001


Page: 1 2 3

Related biology news :

1. Grant advances biochemical engineering laboratory
2. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
3. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
4. McGill Centre for Intellectual Property Policy receives $3 million SSHRC Grant
5. Grant promotes marine ornamental fish aquaculture
6. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
7. Grant renews funding of research toward cloning primates
8. Lipids get the spotlight in new NIGMS Glue Grant
9. Grant funds research to develop tissue-engineered solutions for heart disease
10. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
11. Sea Grant News & Notes for March 26, 2003

Post Your Comments:
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: